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pen accessAbstract Background/aim: Gabapentin is an anticonvulsant drug that is safe and effective for the
treatment of neuropathic pain syndrome, as well as postoperative pain with good results. This pro-
spective randomized study was done to evaluate the effects of preoperative administration of oral
gabapentin (1200 mg) on the intraoperative fentanyl and isoﬂurane consumption, postoperative
analgesic requirements and postoperative pain in patients undergoing radical mastectomy.
Methods: Sixty ASA I and II patients were randomly allocated into two equal groups to receive
oral gabapentin 1200 mg, 2 h before surgery (G group) or control (C group). General anesthesia
was induced and maintained at bispectral index value between 40 and 60. During surgery the
end-tidal isoﬂurane concentrations required to maintain adequate depth of anesthesia and the
required incremental doses of intraoperative fentanyl were recorded. Postoperative pain was
assessed using visual analogue scale (VAS) at rest for 24 h. Postoperatively, whenever visual ana-
logue scale (VAS) was more than 5 or on patients’ demand, analgesia in both groups was provided
with diclofenac sodium (1 mg/kg IM) or tramadol hydrochloride (1 mg/kg IV) as needed. VAS,
analgesics requirements, and side-effects were assessed for 24 h postoperatively.
Results: Intraoperative fentanyl and postoperative analgesic consumption were signiﬁcantly lower
in G group than C group (P< 0.001). Patients in the G group had signiﬁcantly lower end-tidal6235642.
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288 N.M. Doha et al.concentrations of isoﬂurane required to maintain adequate depth of anesthesia (P< 0.05). VAS
was signiﬁcantly lower in G group than C group at the ﬁrst three measurement times (P< 0.01).
The incidence of postoperative nausea and vomiting was signiﬁcantly lower in G group than C
group (30% versus 60% of patients, respectively, P< 0.05). The incidence of dizziness was signif-
icantly higher in the G group than C group (26% versus 3.3% of patients, respectively, P< 0.05).
Conclusion: Gabapentin (1200 mg) administered orally 2 h before surgery decreased the intraoper-
ative fentanyl and isoﬂurane consumption, postoperative analgesic requirements, postoperative
pain, and the incidence of postoperative nausea and vomiting, but increased dizziness.
ª 2010 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
A number of analgesic regimens can be used for pain relief
during surgery. These regimens include the use of opioids, lo-
cal anesthetics, nonsteroidal anti-inﬂammatory drugs (NSA-
IDs), a2-agonists, and cyclooxygenase-2 inhibitors. The
multiplicity of mechanisms involved in pain requires a multi-
modal analgesia regimen, suggesting that a combination of
opioid and non-opioid analgesic drugs may improve analgesic
efﬁcacy and reduce opioid requirements and side-effects after
surgery [1].
Gabapentin is a structural analogue of c-aminobutyric acid,
which was ﬁrst developed as an anticonvulsant drug [2]. It is
safe and effective for the treatment of neuropathic pain syn-
drome [3], as well as for the prevention of postoperative pain
[4]. In animal models of inﬂammatory pain [5], gabapentin
was shown to reduce hyperalgesia and inhibit C-ﬁbre responses
to noxious stimuli [6] by modulating both central and periphe-
ral nociceptive responses [7]. After a single oral dose of 300 mg,
mean maximum plasma concentrations were attained in 2–3 h.
It does not bind with plasma proteins and is not metabolized in
humans. Absorption kinetics of gabapentin is dose-dependent,
possibly due to a saturable transport system [8]. The bio-avail-
ability of a single 300 mg oral dose of gabapentin is 60% and
decreases with increasing dose. Elimination of gabapentin is
by renal clearance and the elimination half-life is about 5–7 h
after a single oral dose of 200–400 mg [9].
As gabapentin has a substantial inhibitory effect on the
development and establishment of allodynia and hyperalgesia
[10], we investigated whether the use of gabapentin could re-
duce intraoperative fentanyl and isoﬂurane consumption, post-
operative analgesics consumption and postoperative pain in
the initial 24 h in patients undergoing radical mastectomy.
2. Material and methods
After acceptance of the Medical Ethics Committee of Al
Monoﬁa University Hospital and obtaining a patient informed
consent, 60 patients of ASA physical status I and II, scheduled
for radical mastectomy surgery were included in this study. Pa-
tients were excluded from the study if they had known allergy
to any of the study drugs, epilepsy, previous treatment with
gabapentin, chronic pain syndrome, psychiatric disorder, sub-
stance abuse, analgesic intake within 48 h before surgery or
inability to understand the visual analogue scale after explana-
tion (a scale for pain assessment in which 0 = no pain and
10 = worst pain).
Patients were randomly allocated (using a computer gener-
ated table) to one of two equal groups, the study group (G
group; n= 30) and the control group (C group; n= 30).Two hours before surgery G group received oral gabapentin
1200 mg (Gabapentine 400 mg, Neurontine, Pﬁzer). In both
groups patients were premedicated with IV midazolam
0.05 mg/kg, 45 min before the scheduled time of surgery. After
the patients had been taken to the operation room, crystalloid
infusion (6–8 ml/kg) was started through a 20-gauge IV can-
nula and mean arterial blood pressure, heart rate, electrocar-
diogram and peripheral oxygen saturation were monitored.
In both groups anesthesia was induced with thiopental sodium
5–7 mg/kg IV and fentanyl 2 lg/kg IV, and intubation of tra-
chea was facilitated with atracurium besylate 0.5 mg/kg. Anes-
thesia was maintained with isoﬂurane 1–1.5% in 50% oxygen/
air. Respiratory frequency and tidal volume were adjusted to
maintain the end-tidal carbon dioxide level at 35–40 mm Hg.
End-tidal isoﬂurane concentrations were monitored continu-
ously and recorded at 10 min (time 1), 30 min after induction
of anesthesia (time 2), 30 min after skin incision (time 3),
and at the end of the surgical procedure (time 4). Isoﬂurane
was titrated guided by bispectral index (BIS = 40–50) and
hemodynamic endpoints (mean arterial pressure and heart rate
within 20% of the preinduction value). Because isoﬂurane ti-
trated using BIS alone might provide hypnosis but insufﬁcient
analgesia, the protocol allowed to increase the inspired isoﬂu-
rane concentration if BIS exceeded 5 (maximum allowable in-
crease of isoﬂurane was 2% for 5 min), if this did not achieve
the targeted values of blood pressure and heart rate, analgesia
in the form of 0.5–1 lg/kg boluses of fentanyl were used as re-
quired. Monitoring during anesthesia comprised continuous
electrocardiogram and heart rate, pulse oximetry, non-invasive
arterial blood pressure, measurement of end-tidal CO2 and
end-tidal isoﬂurane concentration. All parameters were re-
corded at 5-min intervals. After completion of surgery, neuro-
muscular blockade was reversed with atropine 0.02 mg/kg and
neostigmine 0.04 mg/kg and patients were extubated when
adequate spontaneous ventilation was established. Patients
were transferred ﬁrst to the recovery room and then to the sur-
gical ward.
Postoperative pain assessment was monitored by anesthe-
tist in the following times; on arrival to postanesthesia care
unit (time 1~), 2 h after skin closure (time 2~), 6 h after skin
closure (time 3~), 10 h after skin closure (time 4~) and in the
ﬁrst postoperative morning (time 5~). Postoperative analgesia
was provided in both groups based on VAS scores. When
VAS values were 65, diclofenac sodium 1 mg/kg IM was
administered and recorded, if VAS > 5 tramadol 1 mg/kg
was administered. The time to ﬁrst postoperative analgesic
dose and the total amount of analgesic used (mg/24 h) by each
group were recorded.
Any side-effect, such as dizziness, nausea and vomiting,
diarrhea, epigastric discomfort, peripheral edema or headache
Table 1 Demographic data and perioperative characteristics.
G group
(n= 30)
C group
(n= 29)
P value
Age (yr) 47 ± 6 45 ± 8 0.080
Weight (kg) 82 ± 12 79 ± 10 0.161
Height (cm) 164 ± 9 162 ± 10 0.069
Duration of surgery (min) 73 ± 21 71 ± 17 0.680
Duration of anesthesia (min) 80 ± 15 84 ± 14 0.352
Intraoperative fentanyl
consumption (lg)
122 ± 40 148 ± 33 0.001*
Diclofenac consumption (mg) 55 ± 24 95 ± 37 0.000*
Tramadol consumption 103 ± 33 145 ± 45 0.000*
Time to ﬁrst analgesic request (h) 8 ± 6 3 ± 4 0.000*
Values are presented as mean ± SD.
* P< 0.05 denotes statistical signiﬁcance.
Table 2 End-tidal isoﬂurane concentrations at times of
measurement.
Parameter G group
(n= 30)
C group
(n= 29)
P value
Time 1 (5 min after induction) 1.5 ± 0.52 1.6 ± 0.57 0.101
Time 2 (15 min after induction) 1.2 ± 0.2 1.4 ± 0.4 0.013*
Time 3 (30 min after induction) 1.1 ± 0.3 1.3 ± 04 0.030*
Time 4 (45 min after induction) 0.9 ± 0.3 1.1 ± 0.3 0.014*
Time 5 (at the end of the surgery) 0.8 ± 0.2 1.0 ± 0.4 0.010*
Data are mean ± SD.
* P< 0.05 denotes statistical signiﬁcance.
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ondansetron 4 mg IV was administered.
Statistical analysis was performed on a personal computer
using SPSS version 16.0. Data were presented as mean ± stan-
dard deviation (SD) or number (percentage) as appropriate.
VAS scores and end-tidal isoﬂurane concentrations were ana-
lyzed with two-factor ANOVA for repeated measures. The to-
tal amount of intraoperative fentanyl and postoperative
analgesics consumed in each group in 24 h was compared using
an unpaired t test. Chi-square test was used for comparison of
proportions and frequencies between both groups. A value of
P< 0.05 was considered statistically signiﬁcant.3. Results
One patient in the C group was excluded from statistical anal-
ysis because of surgical complications. The patient’s character-
istics, the mean duration of surgery and the mean duration of
anesthesia were comparable between both groups (Table 1).
Intraoperative fentanyl consumption and postoperative anal-
gesic consumption during the ﬁrst 24 h, were signiﬁcantly low-
er in the G group than the C group (Table 1). In addition to the
time to ﬁrst analgesic dose was signiﬁcantly longer in G group
than the C group (Table 1).Figure 1 Intraoperative end-tidal isoﬂuraneExcept for time 1, where there were no difference between
the two groups, the end-tidal isoﬂurane was higher in the C
group than the G group at all other times of measurement
(Table 2 and Fig. 1).
Heart rate and blood pressure did not signiﬁcantly differ
between the two groups throughout the perioperative period.
Indeed hypotension was recorded in 4 patients (13.3%) in G
group and in 6 patients (20%) in C group but this was statis-
tically insigniﬁcant (P> 0.05), and it was corrected by increas-
ing the rate of intravenous ﬂuid infusion. Visual analogue scale
was signiﬁcantly lower in G group than in C group at time 1,
time 2, time 3 and at time 4 but there was no signiﬁcant differ-
ence between both groups at time 5, P> 0.05 (Table 3).
4. Discussion
The present study showed that the preoperative administration
of oral gabapentin 1200 mg signiﬁcantly reduced the intraoper-
ative fentanyl requirements and end-tidal isoﬂurane concentra-
tions required to maintain adequate depth of anesthesia.
Importantly, we used an objective, qualitative measure of
anaesthetic state (BIS) to guide anaesthetic requirements
[11,12].
Our study is the ﬁrst to show that preoperative gabapentin
reduces the intraoperative end-tidal isoﬂurane concentrations
required to maintain adequate depth of anesthesia. However
the effect of preoperative dose of gabapentine on intraopera-
tive anesthetic consumption has been previously reportedconcentrations. EOS = End of surgery.
Table 3 Postoperative visual analogue scale in both groups.
G group
(n= 30)
C group
(n= 29)
P value
Time 1~ (arrival to post
anesthesia care unit)
3.5 ± 2.3 6.1 ± 1.7 0.000*
Time 2~ (2 h after skin closure) 3.2 ± 2.1 4.4 ± 1.2 0.003*
Time 3~ (6 h after skin closure) 1.8 ± 1.7 3.3 ± 1.1 0.001*
Time 4~ (10 h after skin closure) 2.2 ± 1.3 2.9 ± 1.2 0.034*
Time 5~ (ﬁrst postoperative morning) 2.1 ± 1.9 2.4 ± 1.6 0.079
Data are mean ± SD.
* P< 0.05 denotes statistical signiﬁcance.
290 N.M. Doha et al.[13–15]. Hatice et al. [13] reported signiﬁcant decrease in the
total propofol and remifentanil consumption in gabapentin
group compared with phenytoin group in patients undergoing
craniotomy for supratentorial tumor resection. The same ﬁnd-
ing has also previously shown by Alparslan et al. [14] who re-
ported reduction in intraoperative fentanyl consumption in
gabapentin group compared with placebo in patients undergo-
ing ear, nose and throat surgery. In disagreement with us and
the others Prabhakar et al. [15], who reported no difference in
propofol consumption in patients received preoperative gaba-
pentin or placebo but this might be because of the smaller dose
used in their study as they used 800 mg but we used 1200 mg.
The analgesic efﬁcacy of preoperative gabapentin has been
previously reported [16–18]. In the present study a signiﬁcant
reduction in total dose of postoperative analgesics with a sig-
niﬁcant lower pain scores in most times of measurement.
The choice to give gabapentine 2 h before the operation ap-
pears rational in order to attain maximal plasma concentration
at the time of surgical stimuli. Gabapentin crosses rapidly the
blood–brain barrier and consequently, it concentrates in brain
tissue, where it exhibits its effect [19]. Gabapentin has been re-
ported as an anxiolytic drug in previous studies [20,21]. Reduc-
ing preoperative anxiety with gabapentin may have
contributed to the improved postoperative analgesia and to re-
duced analgesic requirements because there is a possible asso-
ciation between preoperative anxiety and postoperative pain
[22].
A possible mechanism for gabapentin-mediated analgesia is
the modulation of glutamate receptors (NMDA and AMPA/
kainate). Gabapentin seems to decrease both NMDA and
non-NMDA-mediated glutamate currents in the superﬁcial
lamina of the rat spinal cord [23] and also inhibits nociceptive
responses to intrathecal NMDA and AMPA in vivo [24]. Fur-
thermore, the analgesic effects of gabapentin are antagonized
by the NMDA/glycine receptor agonist serine [25]. Suarez
et al. [26], suggest that sodium entry through presynaptic
NMDA-R channels facilitates axon excitability and the inter-
action of gabapentin with this mechanism might contribute
to its analgesic beneﬁts. Gabapentin has no direct GABA ac-
tion and does not block GABA uptake or metabolism [27].
Another suggested mechanism for gabapentin is that it binds
to the voltage-dependent calcium channels [28]. All, or any,
of the suggested mechanisms may be responsible for the anal-
gesic action of gabapentin.
Postoperative nausea and vomiting (PONV) during the ﬁrst
24 h was signiﬁcantly lower in gabapentin group. In agreement
with Pandey et al. [29] and Saeed et al. [30] who conclude that600 mg gabapentin 2 h before surgery effectively suppresses
nausea and vomiting after cholecystectomy .The etiology of
PONV following surgery remains unclear. Factors like age
and gender of patient, obesity, technique of anesthesia em-
ployed, presence of post-operative pain, use of opioids for pain
management and elective surgical procedures also inﬂuence the
incidence of PONV. Gabapentin has been reported to be effec-
tive in the treatment of emesis in patients receiving cytotoxic
drugs [31]. The precise mechanism of action is not known
but mitigation of tachykinin neurotransmitter activity has been
postulated to be useful [32]. There is evidence that tachykinin
activity is part of the pathogenesis of chemotherapy-induced
emesis in ferrets, and a selective tachykinin-receptor antagonist
improves both acute and delayed nausea and emesis induced
by chemotherapy [33]. The etiology of PONV in patients
undergoing surgical operation is not identical to that in pa-
tients receiving cytotoxic drugs but the present study assume
that it may be one probable mechanism for prevention of
PONV by gabapentin.
The present study showed that total diclofenac require-
ments were signiﬁcantly less in the gabapentin group. NSAIDs
are commonly used analgesics in surgical procedures for
decreasing pain and opioid requirements [34]. They are well
established, effective, and inexpensive; however, inadequate
analgesia and adverse renal, gastrointestinal, and hemostatic
effects may limit their use in some groups of patients [35,36].
Gabapentin is less well established and is likely to be quite
expensive. For it to have a useful place, it may ultimately need
to be shown to provide better opioid-sparing and/or improved
pain relief compared with the NSAIDs and to be associated
with fewer adverse events. However, in our study, we deter-
mined that 26% of patients encountered dizziness, which
may limit the use of gabapentin in ambulatory patients.5. Conclusion
Gabapentin 1200 mg administered orally 2 h before surgery
signiﬁcantly decreased the intraoperative fentanyl and isoﬂu-
rane consumption, postoperative analgesic requirements, post-
operative pain score, incidence of postoperative nausea and
vomiting but increased incidence of dizziness.References
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